FDA NDC Directory · JSON-LD · Markdown

Bumetanide

NDC 0832-0540 · HUMAN PRESCRIPTION DRUG · TABLET

Generic nameBUMETANIDE
Labeler / ManufacturerUpsher-Smith Laboratories, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA209916
Dosage form / routeTABLET · ORAL
Active ingredientsBUMETANIDE (.5 mg/1)
Marketing started20180130
Marketing ended20260930
Package count1

External sources

Source: openFDA. Public-domain (CC0).